ArticleTranslational vision science & technology2025
Optimized Protocol for Isolation and Culture of Primary Human Corneal Epithelial Cells.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- On the Misuse of Virus-Transformed Human Corneal Epithelial Cells as Surrogates for Normal Cells.Investigative ophthalmology & visual science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Purpose: To establish a reliable method for isolating and culturing high-purity primary human corneal epithelial cells (HCECs) for ophthalmic drug testing. Methods: We present a detailed, step-by-step protocol for the efficient isolation and culture of primary HCECs. This protocol includes the characterization of HCEC morphological responses to varying Ca2+ concentrations in the culture medium. Additionally, immunofluorescence staining with well-established markers is used to identify and confirm the cell types in vitro. A Ca2+ assay is performed to validate the functionality of the cultured primary HCECs. Results: By following the procedures detailed in this protocol, high-purity primary HCECs with strong proliferative capacity and preserved morphological integrity are obtained. Immunofluorescence staining confirms the presence of both limbal stem cells and differentiated corneal epithelial cells in vitro. Additionally, the functional assay demonstrates that the cultured primary HCECs retain the ability to respond to external Ca²⁺ stimuli. Conclusions: This optimized protocol enhances the efficiency and reliability of primary HCECs isolation and culture, enabling the development of a robust in vitro model for studying the mechanisms of ocular diseases. Translational Relevance: Successfully cultured primary HCECs in vitro bridges the gap between laboratory findings and clinical applications, facilitating advancements in therapeutic development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.